中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
11期
96-97
,共2页
慢性肾炎%科素亚%蛋白尿方
慢性腎炎%科素亞%蛋白尿方
만성신염%과소아%단백뇨방
Chronic nephritis%Cozaar%Proteinuria party
目的：分析蛋白尿方与科素亚药物联合应用于慢性肾炎效果。方法选取该院于2010年1月—2014年3月收治的慢性肾炎患者72例。随机分为A、B两组各36例。A组患者住院治疗期间用常规科素亚药物治疗,B组则选用蛋白尿方与科素亚药物联合治疗。均同时行常规药物、运动及饮食指导,治疗一个月,比较相关指标。结果两组患者经治疗一个月后的24 h尿蛋白定量、尿素氮、血肌酐等评价肾功能的指标均明显低于治疗前,且B组各指标数值均显著低于A组,差异显著,P<0.05,具有统计学意义；两组病情好转率比较,B组优于A组,P<0.05。结论蛋白尿方可有效降低慢性肾炎患者的尿蛋白含量,与科素亚药物联合治疗慢性肾炎疾病时可促进科素亚药物的药效,进而显著改善慢性肾炎患者的病情,促进患者病情的好转,最终提高治疗效果。
目的：分析蛋白尿方與科素亞藥物聯閤應用于慢性腎炎效果。方法選取該院于2010年1月—2014年3月收治的慢性腎炎患者72例。隨機分為A、B兩組各36例。A組患者住院治療期間用常規科素亞藥物治療,B組則選用蛋白尿方與科素亞藥物聯閤治療。均同時行常規藥物、運動及飲食指導,治療一箇月,比較相關指標。結果兩組患者經治療一箇月後的24 h尿蛋白定量、尿素氮、血肌酐等評價腎功能的指標均明顯低于治療前,且B組各指標數值均顯著低于A組,差異顯著,P<0.05,具有統計學意義；兩組病情好轉率比較,B組優于A組,P<0.05。結論蛋白尿方可有效降低慢性腎炎患者的尿蛋白含量,與科素亞藥物聯閤治療慢性腎炎疾病時可促進科素亞藥物的藥效,進而顯著改善慢性腎炎患者的病情,促進患者病情的好轉,最終提高治療效果。
목적：분석단백뇨방여과소아약물연합응용우만성신염효과。방법선취해원우2010년1월—2014년3월수치적만성신염환자72례。수궤분위A、B량조각36례。A조환자주원치료기간용상규과소아약물치료,B조칙선용단백뇨방여과소아약물연합치료。균동시행상규약물、운동급음식지도,치료일개월,비교상관지표。결과량조환자경치료일개월후적24 h뇨단백정량、뇨소담、혈기항등평개신공능적지표균명현저우치료전,차B조각지표수치균현저저우A조,차이현저,P<0.05,구유통계학의의；량조병정호전솔비교,B조우우A조,P<0.05。결론단백뇨방가유효강저만성신염환자적뇨단백함량,여과소아약물연합치료만성신염질병시가촉진과소아약물적약효,진이현저개선만성신염환자적병정,촉진환자병정적호전,최종제고치료효과。
Objective To analyze the effect of chronic nephritis by using proteinuria side combined with Cozaar drug.Methods Selected 72 from 2010 January to 2014 March in our hospital were treated patients with chronic nephritis. And were randomly divided into A, B two groups, 36 cases in each group. during treatment in hospital, group A were given conventional medication Cozaar , group B were given proteinuria side combined with Cozaar drug, and were simultaneously given conventional drugs, exercise, and dietary guidance, after one month for treatment, compared the relevant indicators. Results The two groups of patients after one month for treatment targets after 24h urinary protein, blood urea nitrogen, serum creatinine and other evaluation of renal function was significantly lower than before, and the index value of group B were significantly lower than that of group A, the difference was statistically significant(P<0.05), condition improved rate between the two groups, group B was better than that of group A(P<0.05). Conclusion The only effectively reduce proteinuria in patients with chronic urinary protein can promote the efficacy of drugs Cozaar Cozaar with the drug combination treatment of chronic nephritis disease, chronic nephritis and thus significantly improve the patient's condition, and promote the patient's condition better, and ultimately improve the therapeutic effect.
